Dannel Yeo - Publications

Circulating tumor cells predict relapse in head and neck mucosal squamous cell carcinoma.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: August 10, 2025

High mesothelin expression is associated with low cytotoxic T cell infiltration in pancreatic cancer.

Journal: Frontiers in immunology

Published: June 22, 2025

Portal venous circulating tumor cells as a biomarker for relapse prediction in resected pancreatic cancer.

Journal: Cellular and molecular life sciences : CMLS

Published: November 11, 2024

Neoadjuvant triplet immune checkpoint blockade in newly diagnosed glioblastoma.

Journal: Nature medicine

Published: July 24, 2024

Cancer-associated macrophage-like cells as a prognostic biomarker in solid tumors.

Journal: The journal of liquid biopsy

Published: July 10, 2024

Circulating tumor cell detection may offer earlier diagnosis in patients suspected of asbestos-related lung cancer.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: February 13, 2024

Circulating tumor cells: advancing personalized therapy in small cell lung cancer patients.

Journal: Molecular oncology

Published: October 20, 2023

Mesothelin antigen density influences anti-mesothelin chimeric antigen receptor T cell cytotoxicity.

Journal: Cytotherapy

Published: May 31, 2023

Accurate isolation and detection of circulating tumor cells using enrichment-free multiparametric high resolution imaging.

Journal: Frontiers in oncology

Published: January 10, 2023

High mesothelin expression by immunohistochemistry predicts improved survival in pleural mesothelioma.

Journal: Histopathology

Published: November 06, 2022

Locoregional delivery of CAR-T cells in the clinic.

Journal: Pharmacological research

Published: April 29, 2022

The next wave of cellular immunotherapies in pancreatic cancer.

Journal: Molecular therapy oncolytics

Published: March 01, 2022